HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 564 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $10,000 | -47.4% | 162 | -31.6% | 0.00% | 0.0% |
| Q2 2022 | $19,000 | -59.6% | 237 | -46.5% | 0.00% | -50.0% |
| Q1 2022 | $47,000 | -97.9% | 443 | -97.9% | 0.00% | -99.1% |
| Q4 2021 | $2,225,000 | -12.8% | 20,651 | -11.4% | 0.22% | +67.2% |
| Q3 2021 | $2,553,000 | +22.6% | 23,310 | +4.8% | 0.13% | +38.1% |
| Q2 2021 | $2,083,000 | +1.9% | 22,250 | +0.2% | 0.10% | -7.6% |
| Q1 2021 | $2,044,000 | +25450.0% | 22,214 | +19912.6% | 0.10% | +5150.0% |
| Q4 2020 | $8,000 | -99.6% | 111 | -99.5% | 0.00% | -98.4% |
| Q3 2020 | $1,884,000 | +274.6% | 24,260 | +168.2% | 0.12% | +269.7% |
| Q2 2020 | $503,000 | +89.1% | 9,046 | +0.3% | 0.03% | +57.1% |
| Q1 2020 | $266,000 | +2.7% | 9,016 | +26.0% | 0.02% | +31.2% |
| Q4 2019 | $259,000 | +3.6% | 7,156 | -22.3% | 0.02% | -5.9% |
| Q3 2019 | $250,000 | -54.8% | 9,210 | -59.9% | 0.02% | -56.4% |
| Q2 2019 | $553,000 | – | 22,992 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |